See previous post here. Novopharm is the #2 Canadian generic by sales in 2007; ratiopharm was the #4.
Article in NY Times is here. Price: $5 billion.
A simple little decision brings an important reminder
-
The Davies v Lazer Safe decision is a timely reminder that in IP disputes,
leverage often sits in the procedural details. The Court clarified that an
old f...
4 days ago
No comments:
Post a Comment